Institutional Sign In

Go

GlaxoSmithKline Czech Republic - Capital Expenditures (As % of Sales)

GlaxoSmithKline CR`s Capital Expenditures (As % of Sales) reached 0.077 % in 2017. This is 66.8 % less than in the previous year.

$1.99

Buy Capital Expenditures (As % of Sales) data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic % ... ... ... ... ... ...           0.474 0.240 0.245 0.085 0.115    
Bayer Czech Republic % ... ... ...             ... ... ... ... ... ... ...    
GlaxoSmithKline Czech Republic % ... ... ...           ... ... ... ... ... ... ... ...    
Merck Czech Republic % ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...    
Novartis Czech Republic %                       0.077 0.440 0.497 0.327 0.771    
Pfizer Czech Republic % ... ...             ... ... ... ... ... ... ... ...    
Roche Czech Republic % ... ... ...                 1.55 3.38 2.90 3.02 2.16   ...
Sanofi-Aventis Czech Republic % ... ... ... ...               0.144 0.188 0.049 -0.020 0.042    
Servier Czech Republic % ... ... ... ... ... ... ... ... ... ... ... ... 0.354 0.912 1.24 0.676    
Walmark % ... ... ...                 3.35 1.87 12.7 3.29 16.0